Companies: 10,795·Total market cap: $144.5T
Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIONYSEHealthcare● Active
$294.32
$-13.15(-4.28%)
Market Cap$8.0B
P/E Ratio
52W High$343.12
52W Low$218.14
Overview

Bio-Rad Laboratories, Inc. (BIO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BIO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$6.11bio eps ttm · bio earnings per shareEarnings history
PE Ratio (TTM)48.2×bio pe ratio ttm · bio price to earningsPE Ratio deep dive
Revenue (TTM)$2.6Bbio revenue ttm · bio annual revenueFull revenue history
Dividend YieldNo Dividenddoes bio pay dividends · bio dividend yieldDividend history
Shares Outstanding27.3Mbio shares outstanding · bio floatShares outstanding history
Next EarningsJul 30, 2026Est.bio earnings date · bio next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$2.58B▲ +0.65% YoY
202320242025
bio-rad laboratories, inc. revenue · bio revenue 2025
FY 2025Net Income$759.9M▲ +141.20% YoY
202320242025
bio-rad laboratories, inc. net income · bio profit 2025
FY 2025EPS$27.87▲ +142.64% YoY
202320242025
bio eps · bio-rad laboratories, inc. earnings per share 2025
TTM:Revenue: $2.59BNet Income: $168.8MEPS: $6.11View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy14 analystsis bio a buy · bio analyst rating
Strong Buy
1
Buy
7
Hold
6
Sell
0
Strong Sell
0
12-Month Price Target
$310.00Low
$294.32Current
$321.67Avg Target9.29% upside
$335.00High
bio price target · bio 12 month forecast

Total: 14 · Buy rate: 57.1%

The BIO analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $321.67, representing +9.29% upside from the current price of $294.32.

Stock Performance

Full History
1D-4.28%
1W-3.05%
1M+15.73%
3M+9.07%
YTD-2.86%
1Y+30.48%
5Y-49.40%

About Bio-Rad Laboratories, Inc.

CEONorman D. Schwartz
IPO DateFeb 27, 1980
Employees7,700
CountryUS

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates thro…

what is bio-rad laboratories, inc. · bio stock overview · bio-rad laboratories, inc. company profile · who is bio-rad laboratories, inc. ceo · bio NYSE · bio-rad laboratories, inc. headquarters · bio-rad laboratories, inc. business segments

About Stock Overview & Key Data

Bio-Rad Laboratories, Inc. (BIO) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Feb 27, 1980. As of the latest trading session, BIO stock price is $294.32, with a market capitalization of $8.0B. The stock has returned +30.48% over the past 12 months and -2.86% year-to-date.

According to 14 Wall Street analysts, the consensus rating for Bio-Rad Laboratories, Inc. stock is Buy, with an average 12-month price target of $321.67. In fiscal year 2025, Bio-Rad Laboratories, Inc. reported revenue of $2.6B and net income of $759.9M. For detailed data — including Bio-Rad Laboratories, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bio-Rad Laboratories, Inc. (BIO) stock price is $294.32. The stock is traded on NYSE under the ticker symbol BIO. The 52-week range is $218.14 – $343.12.

BIO stock priceBIO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice